Intech Biopharm Corporation (TPEX:6461)

Intech Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.34	198.65	77.73	64.82	220.48	204.69
Short-Term Investments	247.5	60	520	310	115	100
Cash & Short-Term Investments	319.84	258.65	597.73	374.82	335.48	304.69
Cash Growth	-4.20%	-56.73%	59.47%	11.73%	10.11%	9.95%
Accounts Receivable	9.37	9.28	3.05	3.67	15.04	4.87
Other Receivables	56.3	9.83	8.7	7.94	7.94	7.78
Receivables	65.67	19.11	11.74	11.6	22.98	12.65
Inventory	133	63.86	41.53	51.82	59.87	56.97
Prepaid Expenses	18.17	68.65	43.62	40.7	33.74	35.46
Other Current Assets	-	0.06	0.41	0.13	4.26	-
Total Current Assets	536.68	410.32	695.02	479.06	456.33	409.77
Property, Plant & Equipment	1,392	1,885	1,900	2,009	2,090	2,178
Other Intangible Assets	3.09	3.86	4.88	4.8	4.62	4.75
Long-Term Deferred Tax Assets	24.77	24.77	24.77	24.77	24.77	24.77
Other Long-Term Assets	539.66	71.69	86.15	33.17	26.26	4.31
Total Assets	2,497	2,396	2,711	2,551	2,602	2,621
Accounts Payable	13.56	9.82	0.31	1.33	2.4	1.02
Accrued Expenses	26.52	28.82	19.24	23.71	20.82	19.56
Short-Term Debt	-	-	-	-	-	30
Current Portion of Long-Term Debt	361.2	248.82	464.65	265.26	211.66	12.89
Current Unearned Revenue	12.96	81.18	78.54	78.31	78.99	81.21
Other Current Liabilities	5.44	18	5.99	5.23	9.35	9.86
Total Current Liabilities	420.05	386.64	568.73	373.82	323.22	154.52
Long-Term Debt	1,077	1,188	970.41	1,143	940.77	1,138
Long-Term Unearned Revenue	8.84	5.53	2.35	-	-	-
Other Long-Term Liabilities	1.77	1.72	1.74	1.54	-	-
Total Liabilities	1,509	1,582	1,543	1,519	1,264	1,293
Common Stock	1,629	1,379	1,374	1,170	1,163	1,007
Additional Paid-In Capital	195.04	19.76	286.16	195.15	481.32	574.58
Retained Earnings	-836.26	-579.76	-488.08	-327.88	-301.76	-250.37
Comprehensive Income & Other	-	-5.16	-4.32	-5.13	-4.72	-2.7
Shareholders' Equity	987.98	814.28	1,168	1,032	1,338	1,329
Total Liabilities & Equity	2,497	2,396	2,711	2,551	2,602	2,621
Total Debt	1,440	1,436	1,435	1,409	1,152	1,181
Net Cash (Debt)	-1,120	-1,178	-837.33	-1,034	-816.94	-876.4
Net Cash Per Share	-7.72	-8.58	-6.95	-8.90	-8.03	-8.74
Filing Date Shares Outstanding	162.92	137.94	137.41	116.96	116.28	100.73
Total Common Shares Outstanding	162.92	137.94	137.41	116.96	116.28	100.73
Working Capital	116.63	23.68	126.3	105.24	133.11	255.25
Book Value Per Share	6.06	5.90	8.50	8.82	11.50	13.19
Tangible Book Value	984.89	810.42	1,163	1,027	1,333	1,324
Tangible Book Value Per Share	6.05	5.87	8.46	8.78	11.46	13.14
Land	493.72	919.87	919.87	950.72	950.72	950.72
Buildings	748.76	791.07	790.24	798.32	810.2	809.13
Machinery	751.48	724.87	657.12	645.9	633.52	616.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.